Major histocompatibility complex (MHC) molecules are central to development and regulation of the immune system in all jawed vertebrates. MHC class III cytokine genes from the tumor necrosis factor core family, including tumor necrosis factor (TNF) and lymphotoxin alpha and beta (LTA, LTB), are well studied in human and mouse. Orthologues have been identified in several other eutherian species and the cDNA sequences have been reported for a model marsupial, the tammar wallaby. Comparative genomics can help to determine gene function, to understand the evolution of a gene or gene family, and to identify potential regulatory regions. We therefore cloned the genomic region containing the tammar LTB, TNF, and LTA orthologues by “genome walking”, using primers designed from known tammar sequences and regions conserved in other species. We isolated two tammar BAC clones containing all three genes. These tammar genes show similar intergenic distances and the same transcriptional orientation as in human and mouse. Gene structures and sequences are also very conserved. By comparing the tammar, human and mouse genomic sequences we were able to identify candidate regulatory regions for these genes in mammals. Full length sequencing of BACs containing the three genes has been partially completed, and reveals the presence of a number of other tammar MHC III orthologues in this region.   

1.
Altschul SF, Modden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402 (1997).
2.
Bateman AC, Howell WM: Human leukocyte antigens and cancer: is it in our genes? J Pathol 188:231–236 (1999).
3.
Bray N, Dubchak I, Pachter L: AVID: A global alignment program. Genome Res 13:97–102 (2003).
4.
Browning TL, Belov K, Miller RD, Eldridge MDB: Molecular cloning and characterization of the polymorphic MHC class II DBB from the tammar wallaby (Macropus eugenii). Immunogenetics 55:791–795 (2004).
5.
Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B: The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta expression through a TAR-like structure. J Virol 68:2677–2682 (1994).
6.
Chapman MA, Charchar FJ, Kinston S, Bird CP, Grafham D, Rogers J, et al: Comparative and functional analyses of LYL1 loci establish marsupial sequences as a model for phylogenetic footprinting. Genomics 81:249–259 (2003).
7.
Couronne O, Poliakov A, Bray N, Ishkhanov T, Ryaboy D, Rubin E, Pachter L, Dubchak I: Strategies and tools for whole-genome alignments. Genome Res 13:73–80 (2003).
8.
Dorner M, Paabo S: Nucleotide sequence of a marsupial LINE-1 element and the evolution of placental mammals. Mol Biol Evol 12:944–948 (1995).
9.
Foster JW, Graves JA: An SRY-related sequence on the marsupial X chromosome: Implications for the evolution of the mammalian testis-determining gene. Proc Natl Acad Sci USA 91:1927–1931 (1994).
10.
Harrison GA, Deane EM: cDNA sequence of the lymphotoxin beta chain from a marsupial, Macropus eugenii (tammar wallaby). J Interf Cytok Res 19:1099–1102 (1999).
11.
Harrison GA, Deane EM: cDNA cloning of lymphotoxin alpha (LT-α) from a marsupial, Macropus eugenii. DNA Sequence 10:399–403 (2000).
12.
Harrison GA, Broughton MJ, Young LJ, Cooper DW, Deane EM: Conservation of 3′ untranslated region elements in tammar wallaby (Macropus eugenii) TNF-α mRNA. Immunogenetics 49:464–467 (1999).
13.
Houlden BA, Greville WD, Sherwin WB: Evolution of MHC class I loci in marsupials: Characterization of sequences from Koala (Pascolarctos cinereus). Mol Biol Evol 18:1119–1127 (1996).
14.
Klein J, Sato A: Birth of the major histocompatibility complex. Scand J Immunol 47:199–209 (1998).
15.
Koop BF, Hood L: Striking sequence similarity over almost 100 kilobases of human and mouse T-cell receptor DNA. Nat Genet 7:48–53 (1994).
16.
Kulski JK, Shiina T, Anzai T, Kohara S, Inoko H: Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark to man. Immunol Rev 190:95–122 (2002).
17.
Kuprash DV, Osipovich OA, Pokholok DK, Alimzhanov MB, Biragyn A, Turetskaya RL, Nedospasov SA: Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation. J Immunol 156:2465–2472 (1996).
18.
Lam MK-P, Belov K, Harrison GA, Cooper DW: Cloning of the MHC class II DRB cDNA from the brushtail possum (Trichosurus vulpecula). Immunol Lett 76:31–36 (2001a).
19.
Lam MK-P, Belov K, Harrison GA, Cooper DW: An MHC class I gene in the Australian brushtail possum (Trichosurus vulpecula). Immunogenetics 53:430–433 (2001b).
20.
Li DH, Havell EA, Brown CL, Cullen JM: Woodchuck lymphotoxin-α, -β and tumor necrosis factor genes: structure, characterization and biological activity. Gene 242:295–305 (2000).
21.
Miska KB, Miller RD: Marsupial Mhc class I: classical sequences from the opossum, Monodelphis domestica. Immunogenetics 50:89–93 (1999).
22.
Mount SM: A catalogue of splice junction sequences. Nucleic Acids Res 10:459–472 (1982).
23.
O’hUigin C, Sültmann H, Tichy H, Murray B: Isolation of Mhc Class II DMA and DMB cDNA sequences in a marsupial: the gray short-tailed opossum (Monodelphis domestica). J Mol Evol 47:578–585 (1998).
24.
Pfeffer K: Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth F R 14:185–191 (2003).
25.
Sambrook JG, Russell R, Umrania Y, Edwards YJK, Campbell RD, Elgar G, Clark MS: Fugu orthologues of human major histocompatibility complex genes: a genome survey. Immunogenetics 54:367–380 (2002).
26.
Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, et al: Many human L1 elements are capable of retrotransposition. Nat Genet 16:37–43 (1997).
27.
Sinclair AH, Foster JW, Spencer JA, Page DC, Palmer M, Goodfellow PN, Graves JA: Sequences homologous to ZFY, a candidate human sex-determining gene, are autosomal in marsupials. Nature 336:780–783 (1988).
28.
Slade RW, Mayer WE: The expressed class II α-chain genes of the marsupial major histocompatibility complex belong to eutherian mammal gene families. Mol Biol Evol 12:441–450 (1995).
29.
Slade RW, Hale PT, Francis DI, Marshall Graves JA, Sturm RA: The marsupial MHC: The tammar wallaby, Macropus eugenii, contains an expressed DNA-like gene on chromosome 1. J Mol Evol 38:496–505 (1994).
30.
Stone WH, Bruun DA, Fuqua C, Glass LC, Reeves A, Holste S, Figueroa F: Identification and sequence analysis of an Mhc class II B gene in a marsupial (Monodelphis domestica). Immunogenetics 49:461–463 (1999).
31.
Thompson JD, Higgins DG, Gibson TJ: CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680 (1994).
32.
Tsai EY, Yie J, Thanos D, Goldfield AE: Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol 16:5232–5244 (1996).
33.
Voon DC, Subrata LS, Karimi M, Ulgiati D, Abraham LJ: TNF and phorbol esters induce lymphotoxin-beta expession through distinct pathways involving Ets and NF-kappaB family members. J Immunol 172:4332–4341 (2004).
34.
Watanabe Y, Maruoka T, Walter L, Kasahara M: Comparative genomics of the Mill family: a rapidly evolving MHC class I gene family. Eur J Immunol 34:1597–607 (2004).
35.
Wedlock DN, Aldwell FE, Buddle BM: Molecular cloning and characterization of tumor necrosis factor alpha (TNF-alpha) from the Australian common brushtail possum, Trichosurus vulpecula. Immunol Cell Biol 74:151–158 (1996).
36.
Woodburne MO, Rich TH, Springer MS: The evolution of tribospheny and the antiquity of mammalian clades. Mol Phylogenet Evol 28:360–385 (2003).
37.
Worm MM, Tsytsykova A, Geha RS: CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur J Immunol 28:901–906 (1998).
38.
Zenger KR, McKenzie LM, Cooper DW: The first comprehensive genetic linkage map of a marsupial: The tammar wallaby (Macropus eugenii). Genetics 162:321–330 (2002).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.